Global Induced Pluripotent Stem Cells Market
Induced Pluripotent Stem Cells Market Forecast: Comprehensive Global Analysis 2023-2028
12 janv. 2024 05h38 HE | Research and Markets
Dublin, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cells: Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. A groundbreaking research...
Induced Pluripotent Stem Cell ((iPSC) Market
Clinical Trials Using iPSCs for Heart Diseases, Stroke, and Cancer Treatment Propel Induced Pluripotent Stem Cell Market Growth
08 nov. 2023 07h53 HE | Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
22157.jpg
Global Induced Pluripotent Stem Cell Market Report 2023: Cost-effective Benefits of iPSC for Drug Discovery Drive Growth
05 mai 2023 06h53 HE | Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities and Strategies to 2032" report has been added to ResearchAndMarkets.com's offering. ...
Global Induced Pluripotent Stem Cells Production Market
Induced Pluripotent Stem Cells Production Global Market Report 2022: Use Of IPSCs In Regenerative Medicine Presents Opportunities
05 janv. 2023 07h33 HE | Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Cell Culture), By Product, By...
Global Induced Pluripotent Stem Cell (Ipsc) Market
Induced Pluripotent Stem Cell (iPSC) Global Market to Reach $3.57 Billion by 2026
01 août 2022 05h13 HE | Research and Markets
Dublin, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022, By Derived Cell Type, By Application, By End-User" report has been added to...
22157.jpg
Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021: Methods of Commercializing iPSCs are Diverse and Continue to Expand
13 avr. 2021 06h13 HE | Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2021" report has been added to ResearchAndMarkets.com's offering. The main...
22157.jpg
Global Stem Cell Partnering Terms and Agreements Directory 2020: Company A-Z, Headline Value, Stage of Development at Signing, Deal Component Type, Specific Therapy Target & Technology Type
05 févr. 2021 07h13 HE | Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Stem Cell Partnering Terms and Agreements 2010-2020" report has been added to ResearchAndMarkets.com's offering. The Global Stem Cell Partnering...
TMlogo.jpg
Q Therapeutics Announces Joint Venture With REPROCELL
23 avr. 2018 05h00 HE | Q Therapeutics, Inc.
PARTNERSHIP WILL DEVELOP IPSC-DERIVED PRODUCTS TO TREAT CENTRAL NERVOUS SYSTEM DISEASES INVOLVING DEMYELINATION AND DEGENERATIONSALT LAKE CITY and YOKOHAMA, Japan, April 23, 2018 (GLOBE NEWSWIRE) --...
TMlogo.jpg
Q Therapeutics Announces Research Collaboration With REPROCELL
13 déc. 2017 07h00 HE | Q Therapeutics, Inc.
SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury,...